Loading live market data…

Enhabit, Inc.

NYSE:EHAB

$13.8 USD

$0.01 (0.07%)

Volume
652.84K
Average Volume
1.65M
Market Capitalization
$706.91M
P/E Ratio
-230.00
Dividend Yield
0.00%
Price Target
$13.80
Year High
$14.22
Year Low
$6.47
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.56
Source Headline
Enhabit Home Health & Hospice Announces New Chief Executive Officer

DALLAS--(BUSINESS WIRE)--Enhabit, Inc., a leading home health and hospice provider, today announced that Dale Clift has been appointed president and CEO, following the successful completion of the company's acquisition by Kinderhook Industries. Clift succeeds Barb Jacobsmeyer, former president and CEO of Enhabit, who previously announced her intention to step down upon the appointment of a successor. Clift brings decades of leadership experience in home health and hospice care. He previously se.

businesswire.com - 2026-05-18 16:17:00

Fast-paced Momentum Stock Enhabit (EHAB) Is Still Trading at a Bargain

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Enhabit (EHAB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

zacks.com - 2026-05-14 09:55:39

Enhabit (EHAB) Upgraded to Buy: Here's Why

Enhabit (EHAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

zacks.com - 2026-05-13 13:01:11

Enhabit, Inc. (NYSE:EHAB) Receives Consensus Rating of “Hold” from Brokerages

Enhabit, Inc. (NYSE: EHAB - Get Free Report) has been given a consensus recommendation of "Hold" by the nine ratings firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating on the company. The average

defenseworld.net - 2026-04-23 04:24:48

Are CCO, EHAB, APLS, VRE Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws

prnewswire.com - 2026-04-20 18:59:00

Enhabit Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enhabit, Inc. - EHAB

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enhabit, Inc. (NYSE: EHAB) to Kinderhook Industries, LLC. Under the terms of the proposed transaction, shareholders of Enhabit will receive $13.80 per share in cash. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration.

businesswire.com - 2026-04-20 16:00:00

Enhabit Sets Stockholder Meeting Date of May 12, 2026, to Approve Transaction with Kinderhook

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice care provider, today announced that it will hold the special meeting of stockholders (the “Special Meeting”) on May 12, 2026, at 8 a.m. CDT, to vote on the previously announced agreement and plan of merger (the “Merger Agreement”). Pursuant to the Merger Agreement, Anchor Merger Sub, Inc., a Delaware corporation (“Merger Sub”) and a wholly owned subsidiary of Anchor Parent, LLC (“.

businesswire.com - 2026-04-16 16:15:00

Get EHAB Insider Trade Alerts

EHAB Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$12.96

8 analysts

All Time

$12.15

11 analysts

EHAB Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-03-06 TD Cowen Downgrade Buy Hold
2026-02-24 UBS Downgrade Buy Neutral
2026-02-23 Jefferies Downgrade Buy Hold
2026-02-23 Leerink Partners Maintain Market Perform Market Perform
2026-01-22 Oppenheimer Upgrade Perform Outperform
2026-01-13 TD Cowen Upgrade Hold Buy
2026-01-08 UBS Upgrade Neutral Buy
2025-08-08 UBS Maintain Neutral Neutral
2024-12-09 Jefferies Upgrade Hold Buy
2024-11-19 Leerink Partners Maintain Market Perform Market Perform
2024-06-27 B of A Securities Maintain Underperform Underperform
2024-05-14 Leerink Partners Upgrade Underperform Market Perform
2024-05-09 Jefferies Downgrade Buy Hold
2024-03-11 TD Cowen Maintain Market Perform Market Perform
2024-03-07 Oppenheimer Maintain Perform Perform
2024-03-07 UBS Upgrade Sell Neutral
2024-03-06 Jefferies Maintain Buy Buy
2023-08-11 Credit Suisse Maintain Neutral Neutral
2023-07-17 Goldman Sachs Maintain Neutral Neutral
2023-03-16 Goldman Sachs Maintain Neutral Neutral
2023-02-17 Citigroup Maintain Neutral Neutral
2023-02-16 Credit Suisse Maintain Neutral Neutral
2022-12-13 CJS Securities Maintain Market Perform Perform
2022-12-08 UBS Maintain Sell Sell
2022-12-06 Stifel Maintain Buy Buy
2022-11-04 Credit Suisse Maintain Neutral Neutral
2022-10-14 Oppenheimer Maintain Perform Perform
2022-08-30 Jefferies Maintain Buy Buy
2022-08-25 Credit Suisse Maintain Neutral Neutral
2022-08-18 Citigroup Maintain Neutral Neutral
2022-07-13 B of A Securities Maintain Underperform Underperform